UPLOAD: UPLOAD Post author:andrewkaretas Post published:April 1, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingUPLOAD: UPLOAD
CORRESP: CORRESP Post author:andrewkaretas Post published:April 1, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingCORRESP: CORRESP
UPLOAD: UPLOAD Post author:andrewkaretas Post published:April 1, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingUPLOAD: UPLOAD
CORRESP: CORRESP Post author:andrewkaretas Post published:March 29, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingCORRESP: CORRESP
UPLOAD: UPLOAD Post author:andrewkaretas Post published:March 29, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingUPLOAD: UPLOAD
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:March 18, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
S-3: Simplified registration form Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingS-3: Simplified registration form
S-8: Securities offered to employees pursuant to employee benefit plans Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingS-8: Securities offered to employees pursuant to employee benefit plans
10-K: Annual report which provides a comprehensive overview of the company for the past year Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading10-K: Annual report which provides a comprehensive overview of the company for the past year
POSASR: POSASR Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingPOSASR: POSASR